Will Storck

New Capabilities

As of September 2026: Key researcher on the study; performed gene expression analysis

Some prostate cancer tumors survive treatment by changing what they are—losing glandular identity and adopting stem-cell-like traits, a process called transdifferentiation. A University of Michigan team showed in JCI Insight that combining two drug classes reverses many of those changes and sharply slows tumor growth in mice.

Updated Sep 8